More $Megamillions don't go to Yale (UMass & Lyme's ALS is a murder charge)
Mort Zuckerman
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, dpr...@stmartin.edu
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com,
bob.d...@latimes.com
Subject: More $Megamillions don't go to Yale (UMass & Lyme's ALS is a
murder charge)
Date: Oct 13, 2009 5:21 AM
ARTICLE BELOW
=============================
It's like Obama being NOT-BUSH and
getting a Peace Prize for it.
ALS and Lyme:
http://www.actionlyme.org/ALSLYME47.htm
ALS and incompetence to OspA and mycoplasma:
http://www.actionlyme.org/Pam3Cys_Version15.htm
Even the VA recognized the ALS-mycoplasma
connection, finally.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=donta+st[Author]
But IDSA did an end run around R. Blumenthal's
http://www.actionlyme.org/080430_RICO_CABAL_CAVES.htm
subpoena over this very ALS-Lyme outcome: Halperin,
the end-runner around the subpoena with the new and
bogus Neurology "guidelines on Lyme"?
Those ALS-Lyme patients were his
http://www.actionlyme.org/ALSLYME47.htm
would never have tested positive to the
Steere/Dearborn (look at the Western blots in that
report) "case definition" ***which is a murder
charge,*** of course.
That's why the ALDF.com and the EUCALB
disclaim "medical negligence" if anyone
follows their advice:
http://www.relapsingfever.org/CHRONOLOGY_RICO.htm
EUCALB: http://vie.dis.strath.ac.uk/vie/LymeEU/copyright.html ,
ALDF: http://www.aldf.com/Disclaimer.asp
"The American Lyme Disease Foundation, Inc. (ALDF) and its
representatives disclaim any responsibility (including negligence)
from all consequences resulting from any person acting, or refraining
from acting, on information contained in this site."
"EUCALB and its members disclaim any responsibility (including in
negligence) for all consequences of any person acting on, or
refraining from acting in reliance on, information contained in this
site."
- - -
Funny how the AMA never recognized that
the ALDF.com disclaimed EVERY NANOGRAM
OF THEIR SCIENTIFIC GARBAGE - every
bit of this garbage "validated" by Arthur
Weinstein, Superimaginator of Scientific Universes.
Otherwise known as Psyintific Psychosis.
BTW, today NYT's David Brooks tries to change
the topic.
Didn't work, did it? We're not interested
in the perspectives of 30 year "social workers."
Kathleen M. Dickson
http://www.actionlyme.org
http://www.relapsingfever.org
=======================
http://www.telegram.com/article/20091013/NEWS/910130394/1116
By John J. Monahan TELEGRAM & GAZETTE STAFF
jmon...@telegram.com
Add a comment
Lots of kudos go to the Legislature and the governor who understood
this would happen.
-- Dr. Michael Collins,, UMASS MEDICAL SCHOOL CHANCELLOR
The Worcester area’s growing advanced medical research capacity has
drawn tens of millions of dollars in new research grants from the
federal economic stimulus fund, which officials expect to create jobs
now, while laying the groundwork for economic spinoffs for years to
come.
While the state is used to seeing Boston area researchers win large
amounts of National Institutes of Health research dollars, researchers
at the University of Massachusetts Medical School said state-funded
expansion of the school’s research capacity paved the way for the
school to win 71 sizeable NIH research grants totaling more than $21.4
million last week.
Meanwhile researchers at Clark University, Worcester Polytechnic
Institute, and several area biotechnology companies, including
Microbiotix Inc., GLS Synthesis Inc., Iquum Inc. and the Mattek Corp.,
also shared in sizeable allocations for disease and medical research
from the stimulus awards.
UMass Medical School Chancellor Dr. Michael Collins said previous
studies of UMass Medical School’s effect on the local economy show
that for every dollar in increased research funding, the local economy
will see an economic benefit two to three times that amount from
growth in payrolls, supply purchases and support staff.
Moreover, he said, because the grants are awarded based on scientific
merit and peer reviews of the proposed work, the large amount of the
awards shows the high quality of research developing at the medical
campus.
While government stimulus programs have traditionally come in the form
of bricks-and-mortar work on roads and public works construction, Dr.
Collins said scientific discoveries coming from the research will also
improve “the health and wealth” of the nation.
Without major investments in promoting life sciences research by the
state over the last several years, including specific funding of a new
stem cell registry and stem cell bank at the medical school and a $90
million allocation to begin construction of a new RNA interference, or
RNAi, research facility, the school would not be as competitive in
attracting the grants, he said.
“Lots of kudos go to the Legislature and the governor who understood
this would happen,” Dr. Collins said.
Jeffrey A. Simon, director of the state’s economic stimulus plan, said
use of medical research funding as an economic stimulus is
unconventional from an historic point of view, but the $503 million in
stimulus grants going to medical research in the state represents an
investment in immediate economic expansion with an eye to developing
long-term economic growth.
“This is really doing both,” he said, paying for upgrades of research
laboratories, filling gaps in research, and developing cures for
disease, while also creating the potential for economic breakthroughs.
“What we are looking for is the return that comes as a result of
translating knowledge developed in laboratories into new products,” he
said, which can give rise to increased manufacturing eventually in
addition to the benefits of creating new and potentially less costly
treatments for illnesses.
“It’s an area where our institutions in the state are really well-
suited to compete,” he said, noting the state has received 11.5
percent of the NIH stimulus grants so far, second only to California
in the number of grants received.
While the titles of the research projects sound intimidating, such as
Ricardo Gazzinelli’s pending study of the role of polymorpho nuclear
phagocytes in malaria sepsis, the research represented by the stimulus
grants will attempt to solve key scientific questions involving many
diseases. They include herpes, colon cancer, breast cancer, obesity,
Lyme disease, plague, mental retardation, infertility, liver disease,
diabetes and amyotrophic lateral sclerosis, or ALS, among others.
Dr. Terance R. Flotte, dean of the school of medicine, is an
internationally known pioneer in human gene therapy. He is now
investigating the use of gene therapy for genetic diseases that affect
children, including cystic fibrosis, alpha-1 antitrypsin deficiency,
or AAT deficiency, and diabetes.
He said his hope is that the new round of funding will give
researchers a chance to make rapid progress in key areas of their
work. “In many cases these people who got these grants are already
very successful in their fields. This infusion allows them to expand
their lab or tackle particularly complex problems by focusing a lot of
effort on it in a short period of time,” Dr. Flotte said. With the
school recently breaking ground on its massive new RNAi research
facility, he said, the stimulus funding “helps springboard us into
that major build out.” That kind of support from the state government
he said, “definitely set the table,” for the school to succeed in
getting competitive research grants.
He pointed to the work of Dr. Robert H. Brown Jr., a world renowned
scientist on ALS research, as an example. He received a $1.8 million
grant to do gene sequencing to identify abnormal genes in patients
with ALS, also known as Lou Gehrig’s disease, as part of what has
become a determined fight by him to find a cure. Dr. Brown already had
identified some of those abnormalities in prior research, and now he
essentially will be sequencing the entire human genome of ALS
patients.
“This is a huge undertaking and it is so well-suited to this short-
term infusion of dollars to generate this data which then can be mined
for years to come,” Dr. Flotte said. “Dr. Brown has never had the
opportunity for that amount of money at one time,” he said. “It is a
chance of a lifetime for having a short burst of effort” into that
research.
Another example, he said, is the research of Dr. Robert Finberg, a
specialist who studies the innate immune system, the body’s first line
of defense against many diseases. He will be studying how the innate
immune system works against the herpes simplex virus, a virus that
affects some people and not others. The hope is to find out why some
people are able to ward off infection and others have much more
difficulty with it, he said.
The grants come as a result of the late Sen. Edward M. Kennedy’s
efforts to secure $8 billion in medical research funding as part of
the national economic stimulus program earlier this year. U.S. Sen.
Paul G. Kirk joined U.S. Sen. John F. Kerry, both D-Mass., in
announcing the awards, saying the grants “are well-deserved and will
enable our world class universities, hospitals and research centers
across the commonwealth to continue their groundbreaking work in
medical research.”
Add a comment
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci